Open access
Jul 2026
SERPINH1 expression represents a reliable biomarker of human breast cancer aggressiveness.
These findings identify SERPINH1 as a marker of ECM-driven tumour aggressiveness and stromal reprogramming in breast cancer and emerges as a promising prognostic biomarker and a tractable therapeutic target in breast cancer.
M. Scimeca, V. Palumbo, F. Servadei et al.
· Biology Direct · 0 citations